Other languages Biomerica, Inc.

Equities

BMRA

US09061H3075

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-10 pm EDT			5-day change	1st Jan Change
0.5881 ^USD	-4.19%		+5.02%	-52.95%

Apr. 29	Biomerica Enters Distribution Deal to Provide Home Screening Tests in UAE	MT
Apr. 29	Biomerica and UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening with Exclusive Multi-Year Distribution Agreement	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Biomerica Enters Distribution Deal to Provide Home Screening Tests in UAE	Apr. 29
Biomerica and UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening with Exclusive Multi-Year Distribution Agreement	Apr. 29
Biomerica Provides Update on inFoods IBS Expansion	Apr. 15
Biomerica, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024	Apr. 12
Biomerica, Inc. Announces the Appointment of Gary Huff to Its Strategic Advisory Board	Feb. 21
Biomerica, Inc. Appoints Jack Kenny as Chairman of the Board of Directors	Jan. 23
Biomerica, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2023	Jan. 16
Top Premarket Decliners	Dec. 19
Biomerica, Inc. Receives US FDA 510(k) Clearance for their Hp Detect Stool Antigen ELISA Test Product Designed to Detect Presence of H. Pylori Bacteria	Dec. 18
Biomerica, Inc. Expands in Foods IBS Reach with Addition of Several New GI Groups	Nov. 08
Biomerica, Inc. Reports Earnings Results for the First Quarter Ended August 31, 2023	23-10-12
Biomerica Says Dubai Approves Insurance Reimbursement for Colorectal Disease Screening Test	23-09-26
Jack Kenny Joins Biomerica?S Board of Directors	23-08-28
Biomerica, Inc. Reports Earnings Results for the Full Year Ended May 31, 2023	23-08-25
Biomerica's Colorectal Disease Screening Test to be Available in CVS Stores in September	23-08-03
Biomerica Inc. Receives Notice of Patent Allowance in China for A Potential Innovative Technology That Includes an Artificial Intelligence Claim for Predicting Foods That Contain Ingredients That Cause Adverse Reactions in Patients	23-06-21
Biomerica Inc. Announces A Significant Advance in the Management of Irritable Bowel Syndrome	23-05-18
Biomerica, Inc. Announces inFoods IBS Test Now Available at Gastro Health	23-04-17
Biomerica, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2023	23-04-14
Biomerica, Inc. Announces the Launch of InFoods IBS as a Laboratory Developed Test	23-03-08

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Biomerica, Inc.

Equities

BMRA

US09061H3075

Other languages

Filters